Management of Hypokalemic Periodic Paralysis
For acute attacks of hypokalemic periodic paralysis, administer oral potassium chloride at 0.5-1.0 mEq/kg immediately; for long-term prophylaxis, initiate carbonic anhydrase inhibitors (acetazolamide or dichlorphenamide) or potassium-sparing diuretics to prevent recurrent episodes and progressive myopathy. 1
Acute Attack Management
Immediate Potassium Replacement
- Oral potassium chloride is the preferred route at 0.5-1.0 mEq/kg 1
- If oral administration is impossible, use intravenous potassium with mannitol solvent (avoid dextrose-containing solutions as glucose can worsen attacks) 1
- Monitor cardiac rhythm during replacement, as rapid correction can cause arrhythmias
- Expect symptom resolution within hours of adequate potassium replacement 2, 3
Critical Safety Measures
Keep potassium supplements, water, and a telephone at the patient's bedside at all times, regardless of current weakness status 1. This is non-negotiable for patient safety during unexpected attacks.
Monitoring During Acute Episodes
- Serial potassium levels every 2-4 hours until normalized
- Continuous ECG monitoring if potassium <2.5 mEq/L
- Assess muscle strength progression with each potassium check
Long-Term Prophylactic Management
First-Line Prophylaxis
Dichlorphenamide (DCP) is the most effective prophylactic agent, demonstrating statistically significant reductions in both attack rate (P=0.02) and severity-weighted attack rate (P=0.01) in the largest randomized controlled trial 4. In this study, 15 of 34 patients with hypokalemic periodic paralysis preferred DCP over placebo or baseline medication.
Alternative carbonic anhydrase inhibitors:
- Acetazolamide: proven to improve muscle strength in hypokalemic periodic paralysis 4, 5
- Potassium-sparing diuretics (spironolactone): effective alternative when carbonic anhydrase inhibitors are contraindicated 5
Important Caveat
Prophylactic medications are of little value during acute attacks 1—they prevent future episodes but do not treat ongoing paralysis. Never delay potassium replacement to start prophylaxis.
Trigger Identification and Avoidance
Primary Triggers to Eliminate
- Rest after exercise: the most common trigger 1
- High carbohydrate meals: promote insulin release and intracellular potassium shift 1, 6
- High sodium intake: exacerbates attacks 1
- Glucocorticoids: can precipitate severe episodes 7
- Cold exposure, stress, and alcohol 8
Preventive Strategies
- Administer prophylactic potassium before known triggers (e.g., before high-carbohydrate meals)
- Maintain light activity after exercise rather than immediate rest
- Avoid fasting and maintain regular meal schedules
Genetic Testing and Diagnosis
Next-generation sequencing (NGS) panel is the recommended first-tier diagnostic approach 8. A positive genetic test in the context of typical symptoms is the gold standard for diagnosis 1.
- CACNA1S mutations: earlier onset, high male penetrance, more predictable phenotype 8
- SCN4A mutations: greater phenotypic heterogeneity, higher risk of interictal weakness 8
Genotype-phenotype correlations help predict disease course and guide intensity of prophylaxis.
Long-Term Complications and Monitoring
Progressive Myopathy Risk
Patients can develop permanent proximal myopathy over time 6, 5. This makes aggressive prophylaxis and regular follow-up essential, not optional.
Follow-Up Schedule
- Nephrology evaluation every 3-6 months to assess for myopathy development 6
- Muscle strength testing at each visit
- Potassium levels during routine visits (not just during attacks)
- Adjust prophylactic medication doses based on attack frequency
Special Populations
Pregnancy Management
Requires multidisciplinary care model involving neurology, obstetrics, and anesthesiology 8. Firm evidence is lacking, but continue prophylaxis if previously effective, as attack risk may increase peripartum 1.
Perioperative Management
- Check clinical status frequently throughout perioperative period 1
- Ensure potassium availability in recovery area
- Avoid prolonged fasting and glucose-containing IV fluids
- Consider stress-dose prophylactic potassium
Treatment Algorithm Summary
- During acute attack: Oral potassium chloride 0.5-1.0 mEq/kg immediately
- After first attack: Initiate dichlorphenamide or acetazolamide for prophylaxis
- Identify and document all triggers for the individual patient
- Implement trigger avoidance strategies and prophylactic potassium before unavoidable triggers
- Establish regular nephrology follow-up every 3-6 months to monitor for myopathy
- Ensure bedside safety measures are permanently in place
This systematic approach prioritizes preventing the morbidity of recurrent paralysis and the long-term complication of permanent muscle weakness, both of which significantly impact quality of life 8, 6, 5.